ARTICLE | Financial News
Acorda planning $300 million note deal
June 17, 2014 12:43 AM UTC
Acorda Therapeutics Inc. (NASDAQ:ACOR) proposed to raise $300 million through the sale of convertible senior notes due 2021 in an offering underwritten by JPMorgan. The interest rate and conversion pr...